| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Here's a look at the most-watched earnings reports for this week including Nvidia, PDD, Walmart, Palo Alto and more.
JP Morgan analyst Robbie Marcus maintains Medtronic (NYSE:MDT) with a Neutral and raises the price target from $90 to $100.
BofA expects Medtronic to post over 5% second-quarter revenue growth and maintain strong momentum through 2026, driven by robus...
Orchestra BioMed's Virtue® Sirolimus AngioInfusionTM Balloon ("Virtue SAB") is the first non-coated drug-eluting ba...
Citadel founder Ken Griffin poured cold water on Wall Street's obsession with AI at JPMorgan event saying it falls short in...
Truist Securities analyst Richard Newitter maintains Medtronic (NYSE:MDT) with a Hold and raises the price target from $96 t...